loader2
Partner With Us NRI

Mangalam Drugs and Organics Ltd share Price Today

Company details

120.10
128.55
93.80
132.45
6M Return 18.16%
1Y Return 12.28%
Mkt Cap.(Cr) 191.04
Volume 91,584
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 91,584

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Mangalam Drugs and Organics Ltd shares SWOT Analysis

Strengths (7)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (8)

  • Promoters increased pledged shares QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (3)

  • Turnaround companies- loss to profit QoQ
  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength

Threats (1)

  • Companies with growing costs YoY for long term projects

Resistance and support

R1 126.1
R2 131.6
R3 134.6
Pivot

123.12

S1 117.7
S2 114.7
S3 109.2
EMA SMA
117.1
110.5
107.1
108.0
116.5
107.7
103.8
105.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
CITADEL SECURITIES INDIA MARKETS PRIVATE LIMITED Bulk Purchase 2024-02-20 124.33 104257 NSE
NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Purchase 2024-02-20 126.54 86847 NSE
QE SECURITIES LLP Bulk Purchase 2024-02-20 127.23 76361 NSE
Name Category Shares
Dhoot Goverdhan Murlidhar PROMOTER 3.23%
Dhoot Brijmohan Murlidhar PROMOTER 3.08%
Shweta Goverdhan Dhoot PROMOTER 2.59%
Radhika A Dhoot PROMOTER 1.85%
Smita A. Dhoot PROMOTER 1.85%
Rajkumari R. Dhoot PROMOTER 1.74%
Govardhan Murlidhar Dhoot PROMOTER 0.98%
Dhoot Rekha Goverdhan PROMOTER 0.94%
Ajay R Dhoot PROMOTER 0.88%
Dhoot Jyoti Brijmohan PROMOTER 0.66%
Aditya R. Dhoot PROMOTER 0.56%
Shri Jb Pharma Private Limited PROMOTER 16.74%
Shree Kishoriju Trading & Investment Pvt Ltd PROMOTER 6.94%
Shree Rasbihari Trading & Investment Pvt Ltd PROMOTER 6.39%
Raj Exports Pvt Ltd PROMOTER 1.21%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Mangalam Drugs and Organics Ltd Stocks COMPARISON

Financials( in Cr) Mangalam Drugs and Organics Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 120.70 1,573.85 1,477.00 6,428.05 932.60
% Change -0.98 -0.56 -0.70 -0.33 -1.09
Mcap Cr 191.04 377,619.34 119,245.60 107,225.66 94,398.15
Revenue TTM Cr 372.25 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr 1.27 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 0.00 40.47 30.39 20.58 28.60
1 Year Return 12.28 63.08 55.44 45.40 104.50
ROCE 6.17 16.79 14.76 25.99 16.25
ROE 0.84 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 151.96 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,580.50 -5,207.40
LAST 3M 60,912.34 -26,979.54
LAST 6M 120,020.87 9,689.82
LAST 12M 181,151.65 180,381.32

Mangalam Drugs and Organics Ltd Information

Stock PE (TTM)
0
Promoter Holding
50.32%
Book Value
87.7694
ROCE
6.17%
ROE
0.84%
Description
  • Mangalam Drugs and Organics Ltd is an India-based company. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries. Mangalam Drugs and Organics Ltd was incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In July 1, 1997, the company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. In September 22, 1997, the company was converted into a deemed public company and word `private` was deleted from the company`s name. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In August 10, 2001, the company was converted into a full fledged public limited company. In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 2004-05, the capacity is being further enhanced to 960 MTPA. During the year 2005-06, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum. During the year 2007-08, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline & Allied Products from 250 tons to 350 tons. During the year 2009-10, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHO-Geneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.

Registered Address

3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001

Tel : 91-22-22616200/6300/8787
Email : contactus:mangalamdrugs.com
Website : http://www.mangalamdrugs.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532637
NSE Code : MANGALAM
Book Closure Date (Month) :
BSE Group : B
ISIN : INE584F01014

FAQ’s on Mangalam Drugs and Organics Ltd Shares

You can buy Mangalam Drugs and Organics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Mangalam Drugs and Organics Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 28, 2024 03:50 PM the closing price of Mangalam Drugs and Organics Ltd was ₹ 120.70.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 28, 2024 03:50 PM, the market cap of Mangalam Drugs and Organics Ltd stood at ₹ 191.04.

The latest PE ratio of Mangalam Drugs and Organics Ltd as of Feb 28, 2024 03:50 PM is 0

The latest PB ratio of Mangalam Drugs and Organics Ltd as of Feb 28, 2024 03:50 PM is 0.72

The 52-week high of Mangalam Drugs and Organics Ltd is ₹ 132.45 while the 52-week low is ₹ 93.80

Download Our

Download App
market app